Phase II trial of branched peginterferon-alpha 2a (40 kDa) for patients with advanced renal cell carcinoma.
Motzer RJ, Rakhit A, Thompson J, Gurney H, Selby P, Figlin R, Negrier S, Ernst S, Siebels M, Ginsberg M, Rittweger K, Hooftman L.
Motzer RJ, et al. Among authors: figlin r.
Ann Oncol. 2002 Nov;13(11):1799-805. doi: 10.1093/annonc/mdf288.
Ann Oncol. 2002.
PMID: 12419754
Free article.
Clinical Trial.